| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Class Switching | 36 | 2015 | 82 | 7.110 |
Why?
|
| Cytidine Deaminase | 20 | 2015 | 86 | 4.670 |
Why?
|
| B-Lymphocytes | 29 | 2015 | 563 | 3.410 |
Why?
|
| Recombination, Genetic | 23 | 2015 | 256 | 2.420 |
Why?
|
| Immunoglobulin Switch Region | 13 | 2015 | 21 | 2.210 |
Why?
|
| Immunoglobulin Heavy Chains | 11 | 2015 | 47 | 1.540 |
Why?
|
| DNA Repair | 11 | 2014 | 263 | 1.380 |
Why?
|
| DNA-Binding Proteins | 16 | 2015 | 1224 | 1.320 |
Why?
|
| Immunoglobulin G | 8 | 2013 | 467 | 1.310 |
Why?
|
| Immunoglobulin A | 9 | 2009 | 101 | 1.220 |
Why?
|
| Immunoglobulin Isotypes | 8 | 2012 | 24 | 1.170 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 4 | 2014 | 15 | 1.130 |
Why?
|
| DNA Mismatch Repair | 4 | 2014 | 35 | 1.060 |
Why?
|
| DNA Breaks, Double-Stranded | 9 | 2015 | 89 | 1.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 4 | 2014 | 13 | 0.960 |
Why?
|
| DNA Polymerase beta | 3 | 2013 | 6 | 0.960 |
Why?
|
| Spleen | 10 | 2015 | 476 | 0.930 |
Why?
|
| DNA Glycosylases | 4 | 2014 | 22 | 0.880 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 4 | 2014 | 27 | 0.870 |
Why?
|
| Mice | 47 | 2015 | 11125 | 0.870 |
Why?
|
| MutS Homolog 2 Protein | 10 | 2014 | 28 | 0.850 |
Why?
|
| Mice, Knockout | 19 | 2015 | 2161 | 0.830 |
Why?
|
| Animals | 55 | 2015 | 21356 | 0.790 |
Why?
|
| Uracil-DNA Glycosidase | 5 | 2011 | 9 | 0.780 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 129 | 0.730 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2005 | 341 | 0.700 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 403 | 0.700 |
Why?
|
| Lymphocyte Activation | 7 | 2014 | 753 | 0.680 |
Why?
|
| Endonucleases | 3 | 2014 | 84 | 0.680 |
Why?
|
| Base Pair Mismatch | 5 | 2005 | 36 | 0.660 |
Why?
|
| Genes, Immunoglobulin | 6 | 2002 | 33 | 0.650 |
Why?
|
| Gene Rearrangement | 2 | 2014 | 41 | 0.630 |
Why?
|
| Nuclear Proteins | 9 | 2015 | 790 | 0.590 |
Why?
|
| Mice, Inbred C57BL | 14 | 2015 | 3483 | 0.570 |
Why?
|
| Immunoglobulins | 3 | 2015 | 74 | 0.560 |
Why?
|
| DNA | 13 | 2015 | 850 | 0.520 |
Why?
|
| Cells, Cultured | 12 | 2015 | 2187 | 0.520 |
Why?
|
| DNA Repair Enzymes | 3 | 2003 | 38 | 0.520 |
Why?
|
| Interleukin-4 | 8 | 2007 | 147 | 0.510 |
Why?
|
| Germinal Center | 2 | 2014 | 40 | 0.480 |
Why?
|
| Mutation | 6 | 2014 | 2665 | 0.470 |
Why?
|
| DNA Damage | 4 | 2014 | 298 | 0.460 |
Why?
|
| Transforming Growth Factor beta | 4 | 2009 | 181 | 0.460 |
Why?
|
| Histones | 3 | 2014 | 495 | 0.440 |
Why?
|
| NF-kappa B | 4 | 1998 | 434 | 0.440 |
Why?
|
| Mutation Rate | 1 | 2013 | 24 | 0.400 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2013 | 34 | 0.400 |
Why?
|
| B-Lymphocyte Subsets | 3 | 2008 | 44 | 0.380 |
Why?
|
| Deoxyribonuclease (Pyrimidine Dimer) | 1 | 2012 | 2 | 0.370 |
Why?
|
| Neoplasm Proteins | 3 | 2003 | 285 | 0.360 |
Why?
|
| G1 Phase | 3 | 2012 | 58 | 0.360 |
Why?
|
| Base Sequence | 13 | 2007 | 1331 | 0.350 |
Why?
|
| Transcription, Genetic | 7 | 2012 | 903 | 0.330 |
Why?
|
| Adenosine Triphosphatases | 3 | 2003 | 256 | 0.330 |
Why?
|
| Molecular Sequence Data | 13 | 2007 | 1979 | 0.330 |
Why?
|
| Lipopolysaccharides | 6 | 2007 | 625 | 0.310 |
Why?
|
| Tandem Repeat Sequences | 5 | 2015 | 25 | 0.300 |
Why?
|
| DNA Breaks | 1 | 2009 | 8 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2014 | 441 | 0.270 |
Why?
|
| Antioxidants | 1 | 2010 | 249 | 0.270 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 314 | 0.270 |
Why?
|
| CD40 Antigens | 2 | 1998 | 59 | 0.260 |
Why?
|
| Immunoglobulin Constant Regions | 3 | 2005 | 8 | 0.250 |
Why?
|
| Immunoglobulin mu-Chains | 2 | 2005 | 13 | 0.240 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2006 | 37 | 0.240 |
Why?
|
| Binding Sites | 6 | 2015 | 916 | 0.240 |
Why?
|
| Methyltransferases | 1 | 2006 | 67 | 0.240 |
Why?
|
| Models, Genetic | 4 | 2009 | 267 | 0.230 |
Why?
|
| Up-Regulation | 1 | 2007 | 373 | 0.230 |
Why?
|
| Gene Expression Regulation | 7 | 2013 | 1630 | 0.230 |
Why?
|
| Repressor Proteins | 2 | 2011 | 351 | 0.220 |
Why?
|
| Interleukin-5 | 4 | 2007 | 37 | 0.220 |
Why?
|
| Membrane Glycoproteins | 2 | 1998 | 662 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 542 | 0.210 |
Why?
|
| Vertebrates | 1 | 2004 | 42 | 0.210 |
Why?
|
| RNA Polymerase II | 1 | 2004 | 86 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 3 | 1996 | 687 | 0.210 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2002 | 12 | 0.190 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 146 | 0.190 |
Why?
|
| Protein Binding | 4 | 2015 | 1630 | 0.190 |
Why?
|
| Gene Deletion | 2 | 2014 | 312 | 0.190 |
Why?
|
| Multifunctional Enzymes | 2 | 2014 | 19 | 0.180 |
Why?
|
| Flow Cytometry | 3 | 2011 | 661 | 0.180 |
Why?
|
| MutL Protein Homolog 1 | 5 | 2014 | 27 | 0.180 |
Why?
|
| Amino Acid Substitution | 2 | 2015 | 238 | 0.180 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 350 | 0.170 |
Why?
|
| Cell Separation | 3 | 2011 | 147 | 0.170 |
Why?
|
| Humans | 18 | 2015 | 65385 | 0.170 |
Why?
|
| Genes, Switch | 2 | 1992 | 6 | 0.170 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1999 | 4 | 0.150 |
Why?
|
| Exodeoxyribonucleases | 2 | 2009 | 29 | 0.140 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 3 | 2003 | 9 | 0.130 |
Why?
|
| RNA Splicing | 1 | 1999 | 171 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2014 | 43 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 1290 | 0.130 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2008 | 111 | 0.130 |
Why?
|
| Dextrans | 2 | 2007 | 46 | 0.120 |
Why?
|
| Lymphocyte Cooperation | 1 | 1996 | 29 | 0.120 |
Why?
|
| Trans-Activators | 1 | 1998 | 321 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 3 | 2008 | 868 | 0.120 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1996 | 111 | 0.120 |
Why?
|
| DNA, Complementary | 1 | 1996 | 165 | 0.120 |
Why?
|
| DNA, Intergenic | 1 | 2015 | 24 | 0.110 |
Why?
|
| Acetylation | 2 | 2007 | 121 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1996 | 103 | 0.110 |
Why?
|
| DNA End-Joining Repair | 1 | 2015 | 26 | 0.110 |
Why?
|
| Genes, myc | 2 | 2012 | 18 | 0.110 |
Why?
|
| Antibody Formation | 1 | 1995 | 110 | 0.110 |
Why?
|
| Immunoglobulin epsilon-Chains | 1 | 1995 | 3 | 0.110 |
Why?
|
| Carrier Proteins | 4 | 2011 | 716 | 0.110 |
Why?
|
| Antigens, CD | 1 | 1996 | 342 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2014 | 961 | 0.110 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 3 | 2001 | 10 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2015 | 190 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 80 | 0.100 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2014 | 16 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2014 | 23 | 0.100 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2014 | 40 | 0.100 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 35 | 0.100 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 1993 | 27 | 0.100 |
Why?
|
| BRCA1 Protein | 1 | 2014 | 70 | 0.100 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 2007 | 34 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 59 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 168 | 0.100 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 158 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2014 | 183 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2014 | 301 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2014 | 416 | 0.090 |
Why?
|
| S Phase | 1 | 2012 | 79 | 0.090 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1992 | 5 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 345 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 1996 | 1575 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 97 | 0.090 |
Why?
|
| Cell Line | 5 | 2014 | 2024 | 0.090 |
Why?
|
| DNA Replication | 2 | 2014 | 249 | 0.090 |
Why?
|
| DNA Primers | 3 | 2007 | 301 | 0.090 |
Why?
|
| DNA, Superhelical | 1 | 2011 | 8 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 211 | 0.090 |
Why?
|
| Transcription Factors | 2 | 1998 | 1555 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 1998 | 501 | 0.080 |
Why?
|
| RNA Stability | 1 | 2011 | 104 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 1996 | 385 | 0.080 |
Why?
|
| RNA | 3 | 2008 | 426 | 0.080 |
Why?
|
| Genes, Regulator | 1 | 1990 | 28 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2010 | 611 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 237 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2009 | 180 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1038 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2008 | 138 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 1998 | 16 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 233 | 0.070 |
Why?
|
| In Vitro Techniques | 2 | 2002 | 491 | 0.070 |
Why?
|
| CD40 Ligand | 2 | 1998 | 159 | 0.060 |
Why?
|
| Cytosine | 1 | 2007 | 31 | 0.060 |
Why?
|
| Uracil | 1 | 2007 | 36 | 0.060 |
Why?
|
| B-Cell Activating Factor | 1 | 2007 | 9 | 0.060 |
Why?
|
| Peritoneum | 1 | 2006 | 31 | 0.060 |
Why?
|
| PAX5 Transcription Factor | 1 | 2006 | 13 | 0.060 |
Why?
|
| Protein Methyltransferases | 1 | 2006 | 13 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 1999 | 414 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 708 | 0.060 |
Why?
|
| Restriction Mapping | 3 | 1990 | 49 | 0.060 |
Why?
|
| Antibody Diversity | 1 | 2005 | 8 | 0.060 |
Why?
|
| Plasmids | 1 | 2006 | 294 | 0.060 |
Why?
|
| Luciferases | 2 | 1998 | 107 | 0.060 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 2 | 0.060 |
Why?
|
| Germ Cells | 2 | 1999 | 119 | 0.050 |
Why?
|
| Immunoglobulin M | 3 | 1992 | 116 | 0.050 |
Why?
|
| Lymphoma | 1 | 1985 | 101 | 0.050 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2003 | 12 | 0.050 |
Why?
|
| Base Composition | 1 | 2003 | 30 | 0.050 |
Why?
|
| Transfection | 2 | 1998 | 700 | 0.050 |
Why?
|
| Genetic Variation | 1 | 2004 | 394 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2013 | 3148 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 11 | 0.040 |
Why?
|
| STAT6 Transcription Factor | 1 | 1998 | 9 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1998 | 38 | 0.030 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 1998 | 27 | 0.030 |
Why?
|
| Drug Synergism | 1 | 1998 | 142 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 1998 | 51 | 0.030 |
Why?
|
| Cell Division | 1 | 1999 | 450 | 0.030 |
Why?
|
| Exons | 1 | 1999 | 208 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1998 | 257 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 426 | 0.030 |
Why?
|
| Cell Survival | 1 | 1999 | 588 | 0.030 |
Why?
|
| Cell Cycle | 1 | 1999 | 398 | 0.030 |
Why?
|
| Chromosome Deletion | 2 | 1989 | 42 | 0.030 |
Why?
|
| Immunoglobulin E | 2 | 1988 | 81 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1996 | 102 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1995 | 30 | 0.030 |
Why?
|
| Antigens | 1 | 1996 | 145 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 30 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1995 | 28 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2014 | 5 | 0.030 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 1 | 2014 | 7 | 0.030 |
Why?
|
| Mitomycin | 1 | 2014 | 29 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1993 | 296 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1995 | 209 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1995 | 363 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1995 | 300 | 0.030 |
Why?
|
| Female | 2 | 2013 | 34146 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 70 | 0.030 |
Why?
|
| Xanthines | 1 | 1993 | 7 | 0.030 |
Why?
|
| Niacinamide | 1 | 1993 | 33 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 353 | 0.030 |
Why?
|
| Proteins | 1 | 1999 | 764 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 242 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 1998 | 1007 | 0.020 |
Why?
|
| Serine | 1 | 2013 | 90 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1993 | 144 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1588 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 226 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 62 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1992 | 198 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 119 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2011 | 85 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2011 | 156 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 9 | 0.020 |
Why?
|
| DNA Probes | 1 | 1990 | 33 | 0.020 |
Why?
|
| Poly A | 1 | 1990 | 29 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 1996 | 1382 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1989 | 2 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1990 | 75 | 0.020 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2009 | 6 | 0.020 |
Why?
|
| Methylation | 1 | 1989 | 130 | 0.020 |
Why?
|
| Interleukins | 1 | 1988 | 87 | 0.020 |
Why?
|
| Kinetics | 1 | 1990 | 757 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 1990 | 574 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1988 | 541 | 0.020 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 1985 | 5 | 0.010 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1985 | 3 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 513 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 114 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1982 | 63 | 0.010 |
Why?
|
| Hybridomas | 1 | 2001 | 63 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2001 | 115 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1985 | 875 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 924 | 0.010 |
Why?
|
| Male | 1 | 1990 | 31147 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1982 | 34 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1982 | 100 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1982 | 198 | 0.000 |
Why?
|